Nobelis group nasal aspirator translucent chamber 1 unit
Nobelis group nasal aspirator translucent chamber 1 unit
Couldn't load pickup availability
This facial sunscreen from Suavinex, packaged in a 50 ml tube, is designed to protect the skin from the effects of UV rays during sun exposure. Its tailored formula is designed to meet the needs of sensitive skin, especially those of adults and children, by offering a pleasant texture and easy application. This product is distributed by the parapharmacy Pharma+ France, a subsidiary of Groupe Nobélis SASU.
- Sun protection against UVA and UVB rays adapted to the face
- Light, non-greasy texture for comfortable application
Apply evenly to the face before sun exposure. Reapply frequently, especially after swimming, perspiring, or toweling. Avoid contact with eyes. Prolonged sun exposure is not recommended, even when using sunscreen.
Aqua, Ethylhexyl Methoxycinnamate, Glycerin, C12-15 Alkyl Benzoate, Octocrylene, Butyl Methoxydibenzoylmethane, Potassium Cetyl Phosphate, Titanium Dioxide, Cetearyl Alcohol, Glyceryl Stearate, PEG-100 Stearate, Phenoxyethanol, Caprylyl Glycol, Parfum, Disodium EDTA, Tocopheryl Acetate, Sodium Hydroxide. For the full list of ingredients, see package insert.
Legal notices:
The information on this product sheet is provided for information purposes only, in accordance with Regulation (EC) No. 1924/2006 on nutrition and health claims made on foodstuffs, and Article L. 111-1 of the French Consumer Code.
They cannot in any case constitute a medical prescription nor replace the consultation of a qualified health professional. Any use of the product must comply with the instructions, the recommended dosage, and the precautions for use.
In accordance with Article L. 5122-15 of the Public Health Code, Groupe Nobélis declines all responsibility in the event of misuse, self-medication or non-compliance with official recommendations.
Photographs, descriptions, and technical information are non-contractual and are subject to change at any time. The user is encouraged to regularly check for updates or contact a healthcare professional for any treatment-related questions.
